(HealthDay)—Dual antiplatelet therapy (DAPT) continued beyond six months after drug-eluting stent implantation is associated with reduced stent thrombosis and myocardial infarction but also increased bleeding and all-cause ...
Jun 5, 2015
0
12
Technique, talk, and talent were three buzzwords at the 2015 EuroPCR congress. As in years past, the conference featured a mix of breaking news, live case demonstrations, oral and poster sessions, debates, and tips-and-tricks ...
May 22, 2015
0
5
Stent thrombosis following urgent angioplasty for acute heart attack occurred in less than 1% of patients in a large, "real-world" registry, regardless of whether the antithrombotic treatment used during the procedure was ...
May 21, 2015
0
7
Data from the ILUMIEN II trial found that guidance from optimal coherence tomography (OCT) was associated with comparable stent expansion as guidance from intravascular ultrasound (IVUS) in patients undergoing percutaneous ...
May 20, 2015
0
2
An additional 18 months of dual antiplatelet therapy among patients who received a bare metal coronary stent did not result in significant differences in rates of stent thrombosis (formation of a blood clot), major adverse ...
Mar 17, 2015
0
8
Data from a meta-analysis published today in The Lancet found that extended duration dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation was associated with significantly higher rates of mortality ...
Mar 17, 2015
0
4
(Medical Xpress)—Stanford University School of Medicine researchers hunting for a better drug coating for coronary stents, the small mesh tubes used to prop open plaque-filled arteries, have pinpointed a cancer drug as ...
Nov 18, 2014
0
0
Ambulance administration of the antiplatelet medication ticagrelor to patients with a type of heart attack known as ST segment elevation myocardial infarction (STEMI) is not better than hospital administration, in terms of ...
Sep 1, 2014
0
0
Bivalirudin and heparin are two anticoagulant options for patients undergoing coronary stenting for ischemic heart disease. Bivalirudin, a newer anticoagulant, has been touted as being as effective as generic heparin, but ...
Aug 15, 2014
0
0
A new stent covered with biodegradable coating continues to show statistical equivalence to Japan's market leader in cumulative second-year data and subgroup analyses, according to research from the NEXT trial presented at ...
Mar 31, 2014
0
0
